News in brief

Federal judge approves consent decree with Mira Health Products


- Last updated on GMT

Related tags: Dietary supplements, Food and drug administration, Dietary supplement

Federal judge approves consent decree with Mira Health Products
A federal judge in New York has signed a consent decree for permanent injunction between the United States and Mira Health Products Ltd., a dietary supplement manufacturer located in Farmingdale, New York, and Michael S. Ragno and Michael S. Ragno, Jr.

In the summer of 2013, the Food and Drug Administration issued a warning to consumers not to use or purchase Mira’s Healthy Life Chemistry By Purity First B-50 after receiving numerous reports of illness associated with use of the product. An FDA laboratory analysis found that the product contained two drugs that are potentially harmful anabolic steroids—methasterone, a controlled substance, and dimethazine. These ingredients were not listed on the label and should not have been in a dietary supplement because they are illegal drugs and not dietary ingredients.

The company subsequently recalled all dietary supplements manufactured between June 1, 2010 and May 31, 2013.

“By law, dietary supplements must be manufactured according to FDA regulations,”​ said Melinda K. Plaisier, the FDA’s associate commissioner for regulatory affairs. “This consent decree will ensure that this company cannot harm consumers by selling dietary supplements that do not comply with federal manufacturing requirements.”

Mira’s representatives have informed the court that they are out of business and are no longer manufacturing, processing, packing, labeling, holding, or distributing any dietary supplement, any product labeled as such, or any drug.

Under the terms of the consent decree, before Mira can resume operations, the company must first notify the FDA of its intentions at least 60 business days in advance of resuming operations and must retain an independent expert to inspect its operations and certify to the FDA that the necessary corrections have been made.

The company will not be able to resume operations until it receives written notice from the FDA that its operations are compliant with the Federal Food, Drug, and Cosmetic Act and all applicable regulations. The company must also recall and destroy, under the FDA’s supervision, all unexpired drugs and dietary supplements manufactured since Aug. 1, 2010.

Related topics: Regulation

Follow us


View more